Elective and Risk Reducing Salpingo-Oophorectomy

Risk reducing implies ovaries are normal during the time of removal

Elective is ovaries are removed at time of another indicated surgery


Menopause- 51 years, estradiol decreases by 90% because of follicular arrest and estrone becomes dominant estrogen.

Estrone produced after menopause comes from peripheral conversion adrenal androstenedione by aromatase primarily in adipose tissues.

Androstenedione levels by ovary decrease 50% because of ovarian reduction, but adrenal androstenedione remains constant.


Factors favor oophorectomy- genetic susceptibility, bilateral ovarian neoplasms, severe endometriosis, PID, postmenopausal status.

Factors protective ovarian cancer- pregnancy, bilateral tubal ligation, oral contraceptives


Women with highest risk are those with HBOC and HNPCC

Inherited mutations or BRCA1 and BRCA2 account for 10-15% of all ovarian carcinoma. Mucinous and borderline ovarian are not suggestive of BRCA1 and BRCA2.

HNPCC inherited mutation in the DNA mismatch repair genes MSH2, MLHI, PMS2, MSH6. Most common types in women are colon endometrial cancer (40-60%) and ovarian (8-10%).

Criteria BRCA testing

Non- Ashkenazi Jewish-


Ashkenazi Jew-


Criteria for HNCC


Estrogen replacement postmenopausal women have no increased risk in breast cancer or heart disease up to 7.5 years of use. But increased risk of thromboembolic disease and stroke.

Some studies to date suggest that that testosterone therapy and progestin therapy may be the determining factor in breast cancer risk with with postmenopausal hormone therapy.

Bilateral salpingo-oophorectomy should be offered to women with BRCA1 and BRCA2 mutations after completion of childbearing, preferably by age 40.

Bilateral salpingo-oophorectomy may be indicated for breast cancer survivors who have a high risk of ovarian cancer.

Salpingo-oophorectomy also may be indicated for hormonal therapy of breast cancer. Salpingo-oophorectomy appears to be more effective than tamoxifen alone as an adjuvant therapy in premenopausal women with hormone sensitive breast cancer. Ovarian ablation may be beneficial in women younger than 35 years old who are treated with chemotherapy for hormone sensitive breast cancer.

Estrogen receptor positive metastatic breast cancer is treated first with aggressive hormonal therapy that may include suppressing the ovaries either medically or surgically.

Dr. Khalil

You Might Also Enjoy...

Breast Cancer

Breast cancer Occurs when the cells in the breast begin to grow out of control and can then invade nearby tissues or spread throughout the body.

Premenstrual Syndrome

Premenstrual syndrome (PMS) is characterized by the presence of both physical and behavioral symptoms that occur repetitively in the second half of the menstrual cycle.


Osteoporosis, or porous bone, is a disease characterized by low bone mass and structural deterioration of bone tissue, leading to bone fragility and an increased susceptibility to fractures of the hip, spine, and wrist.

Infectious Diseases Lower Genital Tract

Chlamydia is the number one bacterial sexually transmitted disease (STD) in the United States today. Pelvic inflammatory disease (PID), which can be caused by Chlamydia, is a leading cause of infertility, when left untreated.